Pharmakon Advisers runs 1 fund available to UK investors on Funds Benchmark. The book is concentrated in Bond (1 fund). The average ongoing charge (OCF) across the range is 0.01% — competitive for actively-managed funds.
| # | Fund | 1Y | AUM | OCF |
|---|---|---|---|---|
| 1 |
Bond
Biopharma Credit Plc
GB00BDGKMY29
|
+5.4% | — | 0.01% |
Add any fund to a side-by-side comparison with up to 5 competitor funds.
We list 1 Pharmakon Advisers fund available to UK investors. Not every share class is offered by every platform — check your broker's fund list before placing an order. Use the search above each fund to see its full ISIN and pricing details.
Pharmakon Advisers's largest exposure is in Bond . The full breakdown by count is shown above. You can also filter the firm's funds by asset class using the buttons on the Fund Finder.
Open any Pharmakon Advisers fund's detail page to see its quartile rank against peers in the same IA sector, cumulative and discrete performance over 1Y / 3Y / 5Y, risk metrics (volatility, Sharpe, max drawdown), and full holdings breakdown. Performance data is from FE fundinfo and refreshed monthly.
Across the Pharmakon Advisers retail share classes we cover, the average ongoing charge (OCF) is 0.01%. Individual share classes vary — institutional and clean retail classes are typically cheaper than legacy retail classes with embedded platform fees. Each fund's detail page shows the OCF for that specific share class.
The table above lists every Pharmakon Advisers fund we cover, sortable by AUM, 1Y / 3Y / 5Y return, and ongoing charge. The Fund Finder offers more granular filtering across multiple managers at once.